Opportunity Information: Apply for PAR 10 283

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.396 Cancer Biology Research 93.397 Cancer Centers Support Grants.
  • This funding opportunity was created on Feb 25, 2011 and posted on Sep 16, 2010.
  • Applicants must submit their applications by May 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Public and State controlled institutions of higher education State governments Private institutions of higher education.
  • Other Eligible Applicants include the following Eligible Agencies of the Federal Government Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations U.S. Territory or Possession.
Apply for PAR 10 283

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The National Cancer Institute (NCI), within the National Institutes of Health (NIH), released this Funding Opportunity Announcement (FOA) to strengthen the foundational capabilities of Cancer Epidemiology Cohorts (CECs) and to advance methodological research that improves how cohort-based cancer epidemiology is conducted. The central idea is to provide targeted, practical infrastructure support for the core functions that make large, long-running cohort studies useful and sustainable over time. Rather than focusing on a single hypothesis-driven research project, this opportunity emphasizes the shared systems, resources, and methods that allow cohorts to reliably collect, manage, and use data and biospecimens, maintain participant follow-up, and generate high-quality evidence about cancer causes, prevention, detection, and related outcomes. Importantly, the infrastructure supported under this FOA can be used for either existing cohorts or new cohorts, and it is explicitly intended to help cohorts that may already be funded through other mechanisms within NCI, particularly through the Epidemiology and Genetics Program (EGRP) and other parts of the Division of Cancer Control and Population Sciences (DCCPS).

The award mechanism is a U01 cooperative agreement, which signals a collaborative relationship between the funded investigators and NIH/NCI program staff. In practice, cooperative agreements generally involve substantial scientific or programmatic involvement from the funding agency compared to a standard research project grant. For applicants, that typically means the work is expected to align closely with NCI priorities for cohort infrastructure and methods development, and there may be coordinated activities, shared expectations around deliverables, or participation in broader cohort-related initiatives depending on the specific terms of the award.

The announcement lists the opportunity as discretionary funding and associates it with health and education-related activities. It is tied to multiple CFDA numbers that cover a broad range of cancer research areas, including cancer cause and prevention research (93.393), cancer detection and diagnosis research (93.394), cancer biology research (93.396), and cancer centers support grants (93.397). The FOA does not require cost sharing or matching, which reduces barriers for organizations that may not have resources to provide non-federal matching funds.

Funding levels and the number of awards are not specified as fixed amounts. Instead, NCI indicates that the total funds awarded and the number of awards will depend on the quality of applications received, along with the proposed duration and costs. This structure is common when an agency wants flexibility to support a variable number of strong proposals and to scale awards according to the scope of proposed infrastructure and methodological work.

Eligibility is broad and includes many organization types that might operate, host, or support epidemiology cohorts. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, state governments, U.S. territories or possessions, nonprofit organizations (including those with and without 501(c)(3) status, with the exception noted for institutions of higher education), small businesses, and for-profit organizations other than small businesses. The FOA also allows certain additional applicant categories, including eligible federal agencies, foreign (non-U.S.) entities, and regional organizations, indicating that NCI was open to supporting cohort infrastructure and methods work that could involve international collaboration or be housed outside the United States when appropriate.

Key administrative details in the source information include the funding opportunity number PAR 10 283 and the title "Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)." The FOA was posted on September 16, 2010, with an original closing date of July 10, 2013, and a listed current closing date of May 7, 2011, with an archive date of June 7, 2011. For applicants or interested parties who cannot access the full announcement or have technical problems with the online listing, the notice provides contact information for the NIH Office of Extramural Research (OER) webmaster via FBOWebmaster@OD.NIH.GOV and points to the full FOA text hosted on the NIH grants site at http://grants.nih.gov/grants/guide/pa-files/PAR-10-283.html.

Frequently Asked Questions (FAQs)

1. What is this funding opportunity trying to support?

This FOA is intended to strengthen the foundational capabilities of Cancer Epidemiology Cohorts (CECs) and to advance methodological research that improves how cohort-based cancer epidemiology is conducted. The emphasis is on practical, targeted support for core infrastructure and shared systems that make cohorts sustainable and scientifically productive over time.

2. Is this FOA focused on a single hypothesis-driven research project?

No. The opportunity explicitly emphasizes shared cohort infrastructure, resources, and methods rather than a single hypothesis-driven research project. The goal is to support the systems that enable reliable data and biospecimen collection, participant follow-up, data management, and generation of high-quality evidence related to cancer.

3. What kinds of cohort functions are emphasized under this FOA?

Based on the description provided, the FOA emphasizes infrastructure for core cohort functions, including systems and resources to reliably collect, manage, and use data and biospecimens; maintain participant follow-up; and support research outputs relevant to cancer causes, prevention, detection, and related outcomes.

4. Can the supported infrastructure be used for existing cohorts, new cohorts, or both?

Both. The FOA states that the infrastructure supported under this announcement can be used for either existing cohorts or new cohorts.

5. How does this opportunity relate to other NCI funding for cohorts?

This FOA is explicitly intended to help cohorts that may already be funded through other mechanisms within NCI, particularly through the Epidemiology and Genetics Program (EGRP) and other parts of the Division of Cancer Control and Population Sciences (DCCPS).

6. What is the award mechanism for this FOA?

The award mechanism is a U01 cooperative agreement.

7. What does a U01 cooperative agreement generally mean for the relationship with NIH/NCI?

A U01 cooperative agreement signals a collaborative relationship between funded investigators and NIH/NCI program staff and generally involves substantial scientific or programmatic involvement from the funding agency compared to a standard research project grant. The description indicates that funded work is expected to align closely with NCI priorities for cohort infrastructure and methods development, and may include coordinated activities, shared expectations around deliverables, or participation in broader cohort-related initiatives depending on the award terms.

8. Is this funding opportunity discretionary?

Yes. The announcement lists the opportunity as discretionary funding.

9. What kinds of activity areas are associated with this FOA?

The information provided associates the opportunity with health and education-related activities.

10. Which CFDA numbers are associated with this opportunity?

The FOA is tied to multiple CFDA numbers covering a broad range of cancer research areas: 93.393 (cancer cause and prevention research), 93.394 (cancer detection and diagnosis research), 93.396 (cancer biology research), and 93.397 (cancer centers support grants).

11. Does this FOA require cost sharing or matching funds?

No. The FOA does not require cost sharing or matching.

12. How much funding is available and how many awards will be made?

Funding levels and the number of awards are not specified as fixed amounts. NCI indicates that total funds awarded and the number of awards will depend on the quality of applications received and on the proposed duration and costs.

13. What types of organizations are eligible to apply?

Eligibility is broad and includes: public and state-controlled institutions of higher education; private institutions of higher education; state governments; U.S. territories or possessions; nonprofit organizations (including those with and without 501(c)(3) status, with an exception noted for institutions of higher education); small businesses; and for-profit organizations other than small businesses.

14. Are federal agencies eligible to apply?

Yes. The FOA allows certain additional applicant categories, including eligible federal agencies.

15. Are foreign (non-U.S.) organizations eligible to apply?

Yes. The FOA allows foreign (non-U.S.) entities as eligible applicants.

16. Are regional organizations eligible to apply?

Yes. The FOA includes regional organizations among additional eligible applicant categories.

17. What is the funding opportunity number and title?

The funding opportunity number is PAR 10 283. The title is "Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)."

18. When was this FOA posted?

The FOA was posted on September 16, 2010.

19. What are the key dates listed for closing and archiving?

The source information lists an original closing date of July 10, 2013; a current closing date of May 7, 2011; and an archive date of June 7, 2011.

20. Where can applicants find the full FOA text?

The full FOA text is hosted on the NIH grants site at: http://grants.nih.gov/grants/guide/pa-files/PAR-10-283.html

21. Who should be contacted if there are technical problems accessing the online listing?

The notice provides contact information for the NIH Office of Extramural Research (OER) webmaster via email at FBOWebmaster@OD.NIH.GOV.

22. Which NIH institute released this FOA?

The National Cancer Institute (NCI), within the National Institutes of Health (NIH), released this FOA.

23. What is the main long-term purpose of supporting cohort infrastructure under this FOA?

The central purpose is to keep large, long-running cohort studies useful and sustainable over time by supporting the shared systems, resources, and methods that allow cohorts to produce high-quality evidence about cancer-related outcomes, including causes, prevention, and detection.

Browse more business programs for Infrastructure Services

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: State Wildlife Grants Competitive Grant Program

Previous opportunity: Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 10 283

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 10 283) also looked into and applied for these:

Funding Opportunity
Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology (SBIR U43/U44) Apply for PAR 10 286

Funding Number: PAR 10 286
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $150,000
2011 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 11 002

Funding Number: RFA DA 11 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Pre Application for the 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 10 287

Funding Number: PAR 10 287
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Resource Related Research Projects for Development of Animal Models and Related Materials (R24) Apply for PAR 10 289

Funding Number: PAR 10 289
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Research on Malignancies in the Context of HIV/AIDS (R01) Apply for PA 10 290

Funding Number: PA 10 290
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Research on Malignancies in the Context of HIV/AIDS (R21) Apply for PA 10 291

Funding Number: PA 10 291
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Tumor Microenvironment Network (TMEN) (U54) Apply for RFA CA 10 021

Funding Number: RFA CA 10 021
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $700,000
Animal and Biological Material Resource Centers (P40) Apply for PAR 11 001

Funding Number: PAR 11 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 11 005

Funding Number: PAR 11 005
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Comprehensive Partnerships to Reduce Cancer Health Disparities (U54) Apply for RFA CA 11 001

Funding Number: RFA CA 11 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) Apply for PA 11 009

Funding Number: PA 11 009
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PA 11 008

Funding Number: PA 11 008
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R01) Apply for PA 11 006

Funding Number: PA 11 006
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R21) Apply for PA 11 007

Funding Number: PA 11 007
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
HIV Infection of the Central Nervous System (R01) Apply for PA 11 014

Funding Number: PA 11 014
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
National Gene Vector Biorepository and Coordinating Center (P40) Apply for RFA RR 10 010

Funding Number: RFA RR 10 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medical Marijuana Policy Research Exploring Trends and Impacts (R01) Apply for RFA DA 11 008

Funding Number: RFA DA 11 008
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Molecular Genetics of Drug Addiction and Related Co Morbidities (R01) Apply for PA 11 026

Funding Number: PA 11 026
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Support Opportunity for Addiction Research (SOAR) for New Investigators (R03) Apply for RFA DA 11 010

Funding Number: RFA DA 11 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse (R01) Apply for PA 11 027

Funding Number: PA 11 027
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 10 283", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.